Franz Obermayr

Chief Executive Officer at Panoptes Pharma GmbH

55 year

Health Technology

Retail Trade

Profile

Franz Obermayr is the founder and Chief Executive Officer of Panoptes Pharma GmbH since 2013.
He was also the Head of Clinical Development at Nabriva Therapeutics Plc from 2009 to 2013.
In addition, he served as Director of Drug Discovery at GPC Biotech, Inc. Dr. Obermayr was also the Executive Vice President of Clinical Development at Kiora Pharmaceuticals, Inc. in 2021.

Franz Obermayr active positions

Companies	Position	Start
Panoptes Pharma GmbH Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria.	Chief Executive Officer	2013-06-30

All active positions of Franz Obermayr

Former positions of Franz Obermayr

Companies	Position	End
KIORA PHARMACEUTICALS, INC.	Chief Executive Officer	2021-07-25
NABRIVA THERAPEUTICS PLC	Corporate Officer/Principal	2012-12-31
GPC Biotech, Inc. GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA.	Corporate Officer/Principal	-

See the detail of Franz Obermayr's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Franz Obermayr's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
KIORA PHARMACEUTICALS, INC.	Health Technology
NABRIVA THERAPEUTICS PLC	Health Technology

Private companies	2
GPC Biotech, Inc. GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA.	Retail Trade
Panoptes Pharma GmbH Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria.	Health Technology